Schrodinger (NASDAQ:SDGR – Get Free Report) is projected to release its Q3 2025 results after the market closes on Wednesday, November 5th. Analysts expect Schrodinger to post earnings of ($0.72) per share and revenue of $50.5050 million for the quarter. Interested persons can check the company’s upcoming Q3 2025 earningsummary page for the latest details on the call scheduled for Wednesday, November 5, 2025 at 4:30 PM ET.
Schrodinger (NASDAQ:SDGR – Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported ($0.59) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.83) by $0.24. The firm had revenue of $54.76 million for the quarter, compared to the consensus estimate of $52.03 million. Schrodinger had a negative return on equity of 45.70% and a negative net margin of 76.22%.The business’s revenue was up 15.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.66) earnings per share. On average, analysts expect Schrodinger to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.
Schrodinger Stock Up 2.8%
Shares of NASDAQ SDGR opened at $21.04 on Monday. The business’s 50 day moving average price is $20.00 and its two-hundred day moving average price is $21.39. The company has a market cap of $1.55 billion, a PE ratio of -8.48 and a beta of 1.77. Schrodinger has a twelve month low of $16.60 and a twelve month high of $28.47.
Insiders Place Their Bets
Hedge Funds Weigh In On Schrodinger
Several large investors have recently added to or reduced their stakes in SDGR. Bank of America Corp DE increased its stake in Schrodinger by 428.3% in the 2nd quarter. Bank of America Corp DE now owns 606,916 shares of the company’s stock valued at $12,211,000 after buying an additional 492,032 shares during the last quarter. Rubric Capital Management LP lifted its position in shares of Schrodinger by 4.2% during the 2nd quarter. Rubric Capital Management LP now owns 5,000,000 shares of the company’s stock worth $100,600,000 after buying an additional 200,000 shares in the last quarter. Qube Research & Technologies Ltd bought a new position in shares of Schrodinger during the 2nd quarter worth approximately $2,552,000. Engineers Gate Manager LP lifted its position in shares of Schrodinger by 431.8% during the 2nd quarter. Engineers Gate Manager LP now owns 90,882 shares of the company’s stock worth $1,829,000 after buying an additional 73,791 shares in the last quarter. Finally, Marshall Wace LLP bought a new position in shares of Schrodinger during the 2nd quarter worth approximately $1,284,000. Institutional investors own 79.05% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently issued reports on SDGR shares. KeyCorp reduced their price objective on Schrodinger from $30.00 to $28.00 and set an “overweight” rating for the company in a report on Wednesday, October 8th. Wall Street Zen upgraded shares of Schrodinger from a “sell” rating to a “hold” rating in a research report on Saturday, October 25th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Schrodinger in a report on Tuesday, October 14th. Morgan Stanley decreased their price objective on Schrodinger from $28.00 to $19.00 and set an “equal weight” rating for the company in a report on Monday, August 18th. Finally, Barclays assumed coverage on Schrodinger in a report on Thursday, August 14th. They set an “overweight” rating and a $25.00 price target for the company. Four analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Schrodinger currently has a consensus rating of “Hold” and an average price target of $26.29.
Check Out Our Latest Analysis on Schrodinger
Schrodinger Company Profile
Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.
Featured Articles
- Five stocks we like better than Schrodinger
- Stock Dividend Cuts Happen Are You Ready?
- Boeing Closes in on Airbus With Best Delivery Quarter Since 2018
- 3 Best Fintech Stocks for a Portfolio Boost
- Put It on My Card: Why Luxury Brands and Payments Firms Pair Well
- Investing in Construction Stocks
- 3 Safe and Steady Stocks for Any Market
Receive News & Ratings for Schrodinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrodinger and related companies with MarketBeat.com's FREE daily email newsletter.
